Amoul
Amoul is a Shenzhen-based Chinese manufacturer of emergency and critical care medical devices, including CPR machines, ventilators, AEDs, EIT lung imaging, and video laryngoscopes, serving hospitals, EMS providers, and public AED programs across 100+ countries via direct sales, channel partners, and government procurement.
- Company typePrivate
- Founded2001
- HeadquartersShenzhen, China
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Amoul does
Amoul (Shenzhen Anbao Medical Technology Co., Ltd. / 安保医疗) is a Shenzhen-based, privately held Chinese manufacturer of emergency and critical care medical devices founded in 2001. The company designs and produces a comprehensive portfolio of Class II and III medical devices organized around its proprietary CABD framework (Circulation, Airway, Breathing, Defibrillation), spanning cardiopulmonary resuscitation (CPR) machines (E1-E8 series, CPR300), transport and ICU ventilators (T5 5G-enabled, T7, T500, T6, T20, VK200/VK300, VK600), automated external defibrillators (AED i3/i5/i7/i9 plus i6 monitor/defibrillator), airway management (AVL video laryngoscopes, HFCWO vest therapy, suction units), electrical impedance tomography (EIT600/EIT800) for real-time lung imaging, and supporting ICU equipment (syringe/infusion pumps, transfer beds, VTE prevention, temperature management, EtCO2 monitors). The company also addresses home care (Anim ventilators, HO-2000 oxygen concentrator) and first-aid training markets, with 30+ products across 10 categories and 1,000+ patents including 200+ domestic invention patents and PCT filings.
Amoul's business model is hardware sales of medical devices to hospitals, emergency medical services, and public sector customers, with no public pricing or subscription model disclosed. Go-to-market combines a dedicated direct sales organization for strategic accounts with a national channel partner network covering all Chinese provinces, alongside direct government procurement for public AED deployment programs. The company claims 25,000+ domestic customers, exports to 100+ countries, holds 40+ NMPA Class II/III registrations plus CE, FDA, MDL, TGA, and Ukraine CIS certifications, and is the only engineering research center for emergency and life-support medical equipment in Guangdong Province. Adjacent to hardware sales, Amoul operates a 200+ training base network with 3,000+ instructors that has cultivated 2,000,000+ certified personnel and volunteers, generating a '1+2+N' closed-loop solution (intelligent AED + IoT management system + volunteer platform) that pulls through device sales and creates downstream demand for training consumables. The 2026 launch cadence (CPR300, EIT800, T500, integrated emergency device), Little Giant enterprise designation, and selection into China's 11th batch Excellent Domestic Medical Equipment Catalog indicate an active offensive posture in the public emergency and ICU segments.
Amoul firmographics
Firmographics- Name
- Amoul
- Legal name
- 深圳市安保医疗科技股份有限公司
- Website
- https://amoulmed.com
- Company type
- Private
- Founded year
- 2001
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Amoul is a Shenzhen-based Chinese manufacturer of emergency and critical care medical devices, including CPR machines, ventilators, AEDs, EIT lung imaging, and video laryngoscopes, serving hospitals, EMS providers, and public AED programs across 100+ countries via direct sales, channel partners, and government procurement.
- Ownership category
- akta.pro rank
Where Amoul is headquartered
LocationHeadquarters
- HQ city
- Shenzhen
- HQ country
- China
- HQ region
- Asia
Offices2 records
Markets served
Amoul business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Medical Device Hardware Sales: Sale of Class II and Class III medical devices including intelligent ventilators, AED defibrillators, CPR machines, video laryngoscopes, syringe pumps, infusion pumps, and other life-support equipment to hospitals, emergency services, and healthcare institutions.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Medical institution procurement (hospital, emergency services) |
Go-to-market motion3 records
Distribution channels5 records
Marketing channels11 records
Amoul product offering
Product offeringCore offering
Amoul designs, manufactures, and sells emergency and critical care medical devices organized under its proprietary CABD (Circulation-Airway-Breathing-Defibrillation) framework, including intelligent ventilators for transport and ICU use, automated CPR machines, integrated CPR-defibrillators, automated external defibrillators (AEDs), anesthesia video laryngoscopes, electrical impedance tomography (EIT) lung imaging systems, syringe/infusion pumps, and home-care oxygen concentrators and ventilators. The company sells to hospitals, emergency medical services, government health authorities, and public venues in China and more than 100 export countries, supported by a national training network of 200+ bases and 3,000+ instructors.
Product overview
Amoul (深圳市安保医疗科技股份有限公司) is a comprehensive emergency and critical care medical device manufacturer offering 30+ products across 10 categories. The portfolio centers on four core solution areas: C-A-B-D (Compression-Airway-Breathing-Defibrillation) emergency response, including CPR machines (E1-E8 series) and defibrillators (AED i3/i5/i7/i9, monitor i6); respiratory therapy including transport ventilators (T5, T7, T500), ICU ventilators (VK200/VK300, VK600, T20), and humidification systems; airway management with video laryngoscopes (AVL series) and high-frequency oscillation vest systems; and EIT (electrical impedance tomography) imaging (EIT600/EIT800) for lung monitoring. Supporting ICU operations, the company provides syringe/infusion pumps (SP50/IP50), transfer beds, VTE prevention systems, and temperature management. The company also serves home care with oxygen concentrators (HO-2000) and home ventilators (Anim series), plus training equipment for AED and CPR education. Solutions span public first aid, pre-hospital emergency, in-hospital transport, ICU, perioperative care, and neonatal applications.
Differentiator
Problem solved
Functional benefit
Products and services
- CPR300 Integrated CPR Defibrillator Series (心肺复苏除颤仪CPR300系列) Three-in-one device integrating cardiac compression, ventilation, and defibrillation for pre-hospital emergency resuscitation. Follows 2025 latest international CPR guidelines for coordinated compression-analysis-defibrillation workflow.
- Pneumatic-Driven CPR Machine E1/E2/E3 (气动电控型心肺复苏机E1/E2/E3) Pneumatic-driven and electrically-controlled cardiopulmonary resuscitation machine for automated chest compressions during emergency resuscitation.
- Electric-Driven CPR Machine E5/E6 (电动电控型心肺复苏机E5/E6) Electric-driven and electrically-controlled cardiopulmonary resuscitation machine with precision compression control for emergency cardiac arrest treatment.
- Electric-Driven CPR Machine E7/E8 (电动电控型心肺复苏机E7/E8) Advanced electric-driven and electrically-controlled cardiopulmonary resuscitation machine with enhanced performance for critical care transport and treatment.
- Cardiac Resuscitation Pump (心脏按压泵)
- Anesthesia Video Laryngoscope AVL1000/2000 (麻醉视频喉镜AVL1000/2000)
- Anesthesia Video Laryngoscope AVL-3M Series (麻醉视频喉镜AVL-3M系列)
- High-Frequency Chest Wall Oscillation Vest Therapy System P30/P20 (高频振动排痰机P30/P20)
- Electric Suction Unit (电动吸痰器)
- Emergency Transport Ventilator T5 (急救转运呼吸机T5)
- Emergency Transport Ventilator T7 (急救转运呼吸机T7)
- Turbine-Driven ICU & Transport Ventilator T6 (电动电控治疗转运一体机T6)
- Transport Ventilator T500 (转运呼吸机T500)
- High-Frequency Invasive Ventilator T20 (高频有创呼吸机T20)
- ICU Ventilator VK600 (呼吸机VK600)
- Critical Care Ventilator VK300/VK200 (重症治疗呼吸机VK300/VK200)
- Respiratory Humidifier 68F (呼吸湿化治疗机68F)
- Air Compressor C30C20 (空压机C30C20)
- Automated External Defibrillator AED i3/i5 (自动体外除颤仪i3/i5)
- Automated External Defibrillator AED i7/i9 (自动体外除颤仪i7/i9)
- Defibrillator Monitor i6 (除颤监护仪i6)
- EMT First Aid Kit (EMT急救包)
- Electrical Impedance Tomography System EIT600/EIT800 (胸阻抗断层成像仪EIT600/EIT800)
- Multifunctional Transfer Bed ETB-2 (多功能转运床ETB-2)
- Intermittent Pneumatic Compression VTE Prevention System (间歇脉冲加压抗栓系统)
- SP50 Syringe Pump / IP50 Infusion Pump (SP50系列注射泵/IP50系列输液泵)
- Vein Transilluminator (静脉显像仪)
- Portable EtCO2 Monitor (便携ETCO₂监测仪)
- Medical Temperature Control Instrument TC100/TC200 (医用控温仪TC100/TC200)
- AED Training Simulator (AED训练仪)
- CPR Training Manikin with Blood Flow Simulation (血流型CPR培训模型)
- Precise CPR Feedback System (精准CPR反馈系统)
- Medical Oxygen Concentrator HO-2000 (医用制氧机HO-2000)
- Home Care Ventilator Anim Series (家用呼吸机Anim系列)
- Defibrillation Monitor Tester (除颤监护测试仪)
- Respiratory and Anesthesia Gas Flow Analyzer VT2000 (呼吸麻醉气流分析仪VT2000)
Quantifiable outcome
- AED successfully saved lives at浏阳市镇头镇第四医院 and南宁市马山县人民医院 during 2026 Spring Festival within 4-minute window.
- +3 more outcomes
Companies that use Amoul
Customer profileNamed customers5 records
Segments6 records
Ideal customer profiles4 records
Amoul technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Amoul partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and historical.
- 武汉大学 (Wuhan University)coreWuhan University leads the national science and technology major project on 'High-efficiency Anti-biofilm Materials R&D and Validation for ICU Medical Devices and Environmental Surfaces.' 安保医疗 participates as a project partner, contributing to the development of new materials and technologies for hospital infection prevention and control. The project is led by Professor Yuan Yufeng, Vice President of Wuhan University, and supervised by academicians including Cai Xiujun and Zhou Xiang.
- 美国知名急救产品企业 (US Emergency Product Company)historicalAt founding in 2001, 安保医疗 served as the exclusive China agent for US, Canada, and Germany-based emergency product manufacturers. This was a historical channel arrangement that preceded the company's own product development starting in 2004.
- 德国知名急救产品企业 (German Emergency Product Company)historicalAt founding in 2001, 安保医疗 served as the exclusive China agent for US, Canada, and Germany-based emergency product manufacturers. This was a historical channel arrangement that preceded the company's own product development starting in 2004.
- 加拿大知名急救产品企业 (Canadian Emergency Product Company)historicalAt founding in 2001, 安保医疗 served as the exclusive China agent for US, Canada, and Germany-based emergency product manufacturers. This was a historical channel arrangement that preceded the company's own product development starting in 2004.
Scale indicators11 records
Recent moves6 records
Expansion highlights6 records
Amoul competitors and assessment
Company assessmentBroad incumbents
- Medtronic: Global medical device giant with significant presence in emergency response, defibrillation (via historical Physio-Control/LifePak), and respiratory interventions. Competes with Amoul's defibrillation/AED and airway management portfolio in mature hospital markets.
- GE HealthCare: Global incumbent in patient monitoring, anesthesia, and respiratory care. Overlaps with Amoul's perioperative (anesthesia video laryngoscope) and ICU ventilation/patient monitoring portfolio in hospital procurement globally.
- Philips (Royal Philips): Global incumbent in respiratory care (hospital ventilators, CPAP/BiPAP) and emergency care/ AED solutions. Competes with Amoul in ICU ventilation and home respiratory segments in overseas markets.
- ResMed: Global leader in sleep apnea and home respiratory care (CPAP, BiPAP). Competes with Amoul's Anim home ventilator series in the homecare respiratory segment, particularly in export markets.
- Drägerwerk: German global leader in anesthesia workstations, ICU and transport ventilators, and patient monitoring. Competes with Amoul's ventilator and airway management portfolio in mid/high-tier Chinese hospitals and overseas export markets where Amoul targets.
Direct peers
- ZOLL Medical (Asahi Kasei): Specialist in defibrillators, AEDs, and CPR assistance devices (AutoPulse). Closest direct competitor to Amoul's CPR300 integrated CPR-defibrillator and AED portfolio in EMS, hospital, and public access segments.
- Hamilton Medical: Swiss specialist in ICU and transport ventilators with strong clinical brand. Direct competitor in the high-end transport/ICU ventilator segment where Amoul's T-series and VK-series compete globally.
- Yuwell Medical: Major Chinese medical device manufacturer with strong home care respiratory product lines (oxygen concentrators, CPAP/BiPAP, nebulizers) and expanding hospital channel presence. Direct competitor in Amoul's home care (Anim ventilators, HO-2000 oxygen concentrator) and adjacent hospital respiratory segments.
- Mindray: Shenzhen-based global medical device leader with overlapping portfolios in patient monitoring, ventilators, AEDs, and infusion pumps. Mindray is Amoul's most direct domestic competitor with vastly larger scale and global reach, competing head-to-head in hospital procurement.
- Comen Medical: Shenzhen-based Chinese manufacturer of ventilators, patient monitors, and neonatal care equipment. Direct competitor in the Chinese hospital respiratory and ICU equipment market with comparable product breadth.
Market position
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Amoul social profiles
Digital presenceAmoul compliance and trust
Trust signalCompliance8 records
Amoul financial estimates
Financial estimateRevenue estimate
Valuation estimate
Amoul leadership team
Management profileNumber of profiles
Profiles5 records
Amoul funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Amoul M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Amoul
What does Amoul do?
Amoul designs, manufactures, and sells emergency and critical care medical devices organized under its proprietary CABD (Circulation-Airway-Breathing-Defibrillation) framework, including intelligent ventilators for transport and ICU use, automated CPR machines, integrated CPR-defibrillators, automated external defibrillators (AEDs), anesthesia video laryngoscopes, electrical impedance tomography (EIT) lung imaging systems, syringe/infusion pumps, and home-care oxygen concentrators and ventilators. The company sells to hospitals, emergency medical services, government health authorities, and public venues in China and more than 100 export countries, supported by a national training network of 200+ bases and 3,000+ instructors.
Is Amoul a public or private company?
Amoul is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Amoul founded?
Amoul was founded in 2001. It employs 501 to 1,000 people.
Where is Amoul based?
Amoul is headquartered in Shenzhen, China, in the Asia region.
How does Amoul make money?
One revenue line is on record: medical Device Hardware Sales.
Who are Amoul's main competitors?
Broad incumbents on record are Medtronic, GE HealthCare, Philips (Royal Philips), ResMed and Drägerwerk. Direct peers are ZOLL Medical (Asahi Kasei), Hamilton Medical, Yuwell Medical, Mindray and Comen Medical.
Does Amoul have an API?
No public API is recorded for Amoul.